Abstract
The ethyl ester of eicosapentaenoic acid (EPA) is the only pure EPA-containing lipid available in bulk for oral administration. However, there is doubt as to whether EPA ethyl ester can efficiently increase the plasma levels of EPA in comparison with the ability of other kinds of EPA-containing lipids to do so. Therefore, two other kinds of EPA-containing lipids were prepared to study the efficiency of oral administration of those lipids for increasing the EPA content in plasma phospholipids and cholesteryl esters. EPA-containing lipids which were investigated were [A], 1,2,3-trieicosapentaenoyl-glycerol, [B] 2-eicosapentaenoyl-phosphatidylcholine and [C] ethyl ester of EPA. An adjusted amount of lipids [A], [B] and [C] was administered to rats through a gastric tube for 4 days (the first experiment) or for 10 days (the second experiment), and the fatty acid composition of plasma phospholipids and cholesteryl esters was determined. In the first experiment, there were no significant differences in the efficiency for increasing EPA levels in either phospholipids or cholesteryl esters among the lipids. In the second experiment, the EPA levels of both plasma phospholipids and cholesteryl esters of rats administered ethyl ester of EPA were significantly higher than those of rats administered 2-eicosapentaenoyl-phosphatidylcholine. The EPA levels of the rats administered 1,2,3-trieicosapentaenoylglycerol were between the levels of the two groups mentioned above, but the differences in the EPA levels were not significant. Although an ethyl ester-type molecule is not a naturally occurring lipid, ethyl ester of EPA is equal to 1,2,3-trieicosapentaenoyl-glycerol and appears to be superior to 2-eicosapentaenoyl-phosphatidylcholine as to the efficiency for increasing EPA levels in total plasma phospholipids and plasma cholesteryl esters.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AA:
-
arachidonic acid
- CE:
-
cholesteryl esters
- EE:
-
ethyl ester
- EPA:
-
eicosapentaenoic acid
- PC:
-
phosphatidylcholine
- PL:
-
phospholipids
- TG:
-
triglycerides
References
Dyerberg, J., Bang, H.O., and Hjørn, N. (1975)Am. J. Clin. Nutr. 28, 958–966.
Bang, H.O., Dyerberg, J., and Hjørn, N. (1976)Acta Med. Scand. 200, 69–73.
von Lossonczy, T.O., Ruiter, A., Bronsgeest-Schoute, C.M., van Gent, C.M., and Hermus, R.J.J. (1978)Am. J. Clin. Nutr. 31, 1340–1346.
Siess, W., Roth, P., Scherer, B., Kurzmann, I., Böhlig, B., and Weber, P.C. (1980)Lancet 1, 441–444.
Culp, B.R., Lands, W.E.M., Lucchesi, B.R., Pitt, B., and Romson, J. (1980)Prostaglandins 20, 1021–1031.
Goodnight, S.H., Jr., Harris, W.S., and Connor, W.E. (1981)Blood 58, 880–885.
Sanders, T.A.B., Vickers, M., and Haines, A.P. (1981)Clin. Sci. 61, 317–324.
Hirai, A., Terano, T., Hamazaki, T., Sajiki, J., Kondo, S., Ozawa, A., Fujita, T., Miyamoto, T., Tamura, Y., and Kumagai, A. (1982)Tromb. Res. 28, 285–298.
Hamazaki, T., Nakazawa, R., Tateno, S., Shishido, H., Isoda, K., Hattori, Y., Yoshida, T., Fujita, T., Yano, S., and Kumagai, A. (1984)Kidney Int. 26, 81–84.
Hay, C.R.M., Durber, A.P., and Saynor, R. (1982)Lancet 1, 1269–1272.
Terano, T., Hirai, A., Hamazaki, T., Kobayashi, S., Fujita, T., Tamura, Y., and Kumagai, A. (1983)Atherosclerosis 46, 321–331.
Kobayashi, S., Hamazaki, T., Hirai, A., Terano, T., Tamura, Y., Kanakubo, Y., Yoshida, S., Fujita, T., and Kumagai, A. (1985)Clin. Hemorheol. 5, 493–505.
Hamazaki, T., Hirai, A., Terano, T., Sajiki, J., Kondo, S., Fujita, T., Tamura, Y., and Kumagai, A. (1982)Prostaglandins 23, 557–567.
Lasserre, M., Mendy, F., Spielmann, D., and Jacotot, B. (1985)Lipids 20, 227–233.
Kaluzny, M.A., Duncan, L.A., Merritt, M.V., and Epps, D.E. (1985)J. Lipid Res. 26, 135–144.
Iritani, N., and Fujikawa, S. (1982)J. Nutr. Sci. Vitaminol. 28, 621–629.
Balasubramaniam, S., Simons, L.A., Chang, S., and Hickie, J.B. (1985)J. Lipid Res. 26, 684–689.
Kobatake, Y., Kuroda, K., Jinnouchi, H., Nishide, E., and Innami, S. (1984)J. Nutr. Sci. Vitaminol. 30, 357–372.
Sanders, T.A.B., and Younger, K.M. (1981)Br. J. Nutr. 45, 613–616.
Singer, P., Jaeger, W., Wirth, M., Voigt, S., Nauman, E., Zimontkowski, S., Hajdu, I., and Goedicke, W. (1983)Atherosclerosis 49, 99–108.
Fischer, S., and Weber, P.C. (1984)Nature 307, 165–168.
Popp-Snijders, C., Schouten, J.A., de Jong, A.P., and van der Veen, E.A. (1984)Scand. J. Clin. Lab. Invest. 44, 39–46.
von Schacky, C., and Weber, P.C. (1985)J. Clin. Invest. 76, 2446–2450.
Herold, P.M., and Kinsella, J.E. (1986)Am. J. Clin. Nutr. 43, 566–598.
Author information
Authors and Affiliations
About this article
Cite this article
Hamazaki, T., Urakaze, M., Makuta, M. et al. Intake of different eicosapentaenoic acid-containing lipids and fatty acid pattern of plasma lipids in the rats. Lipids 22, 994–998 (1987). https://doi.org/10.1007/BF02536438
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02536438